446 related articles for article (PubMed ID: 26430399)
1. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
Chen LP; Li C; Wen TF; Yan LN; Li B; Yang JY
Pak J Med Sci; 2015; 31(4):763-9. PubMed ID: 26430399
[TBL] [Abstract][Full Text] [Related]
2. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
[TBL] [Abstract][Full Text] [Related]
3. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation.
Bhangui P; Vibert E; Majno P; Salloum C; Andreani P; Zocrato J; Ichai P; Saliba F; Adam R; Castaing D; Azoulay D
Hepatology; 2011 May; 53(5):1570-9. PubMed ID: 21520172
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for hepatocellular carcinoma from living-donor
Akamatsu N; Kokudo N
Hepatobiliary Surg Nutr; 2016 Oct; 5(5):422-428. PubMed ID: 27826557
[TBL] [Abstract][Full Text] [Related]
5. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
[TBL] [Abstract][Full Text] [Related]
6. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma Within or Beyond the Milan Criteria: Comparable Long-Term Outcomes.
Lee S; Song GW; Kim KW; Kwon JH; Lee SG
Transplant Proc; 2021; 53(1):92-97. PubMed ID: 33288309
[TBL] [Abstract][Full Text] [Related]
7. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
[TBL] [Abstract][Full Text] [Related]
8. The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.
Chen J; Xu X; Wu J; Ling Q; Wang K; Wang W; Zhang M; Shen Y; Zhou L; Xie H; Zheng S
PLoS One; 2014; 9(3):e93128. PubMed ID: 24676010
[TBL] [Abstract][Full Text] [Related]
9. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
10. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
11. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
[TBL] [Abstract][Full Text] [Related]
12. Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience from Pakistan.
Bhatti ABH; Dar FS; Qureshi AI; Khan NY; Zia HH; Haider S; Shah NH; Rana A
J Clin Exp Hepatol; 2019; 9(6):704-709. PubMed ID: 31889751
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
[TBL] [Abstract][Full Text] [Related]
15. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation.
Di Sandro S; Slim AO; Giacomoni A; Lauterio A; Mangoni I; Aseni P; Pirotta V; Aldumour A; Mihaylov P; De Carlis L
Transplant Proc; 2009 May; 41(4):1283-5. PubMed ID: 19460539
[TBL] [Abstract][Full Text] [Related]
16. Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.
Wan P; Zhang JJ; Li QG; Xu N; Zhang M; Chen XS; Han LZ; Xia Q
World J Gastroenterol; 2014 Apr; 20(15):4393-400. PubMed ID: 24764678
[TBL] [Abstract][Full Text] [Related]
17. Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.
Gunay Y; Guler N; Yaprak O; Dayangac M; Akyildiz M; Altaca G; Yuzer Y; Tokat Y
Indian J Surg; 2015 Dec; 77(Suppl 3):950-6. PubMed ID: 27011489
[TBL] [Abstract][Full Text] [Related]
18. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
[TBL] [Abstract][Full Text] [Related]
20. Living donor liver transplantation for hepatocellular carcinoma.
Lee SG; Moon DB
Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]